Clinical Trials Logo

Tuberculosis Infection clinical trials

View clinical trials related to Tuberculosis Infection.

Filter by:

NCT ID: NCT01689831 Recruiting - Clinical trials for Tuberculosis Infection

Dose Study of Tuberculin Purified Protein Derivative (JHP/Dose)

Start date: May 2012
Phase: Phase 2
Study type: Interventional

Dose comparison study of tuberculin purified protein derivative (PPD)Aplisol with the standard tuberculin purified derivative (PPD-S2).

NCT ID: NCT01434758 Completed - Clinical trials for Tuberculosis Infection

Evaluating Diagnostics for Paediatric Tuberculosis by Blood Culture

Start date: April 2011
Phase: N/A
Study type: Observational

Detection of M. tuberculosis in clinical specimens of children has a low sensitivity because specimens are either difficult to collect or contain low levels of M. tuberculosis. Diagnostic criteria are non-specific and culture confirmation is challenging, as sputum samples are not often obtainable from small children and specimens typically have low yield. Although children are typically thought to have paucibacillary disease, they are at greater risk for dissemination of TB. This may allow for detection of Mycobacterium tuberculosis from other bodily fluids than sputum or gastric aspirate, including blood and urine. Unfortunately, little is known about the overall yield from these various specimens. From pilot data collected among adults and children in Tugela Ferry, we know that it is feasible to collect and test various bodily fluid specimens for TB culture. This study aim to test the hypothesis that blood and urine cultures will detect Mycobacterium tuberculosis from children suspected of disseminated TB, and that a proportion of these non-sputum bodily fluids will detect both drug-susceptible and drug-resistant tuberculosis when sputum or gastric culture does not.